Literature DB >> 29212740

IL-23 (Interleukin-23)-Producing Conventional Dendritic Cells Control the Detrimental IL-17 (Interleukin-17) Response in Stroke.

Mathias Gelderblom1, Mattia Gallizioli2, Peter Ludewig2, Vivien Thom2, Priyadharshini Arunachalam2, Björn Rissiek2, Christian Bernreuther2, Markus Glatzel2, Thomas Korn2, Thiruma Valavan Arumugam2, Jan Sedlacik2, Christian Gerloff2, Eva Tolosa2, Anna M Planas2, Tim Magnus1.   

Abstract

BACKGROUND AND
PURPOSE: Inflammatory mechanisms can exacerbate ischemic tissue damage and worsen clinical outcome in patients with stroke. Both αβ and γδ T cells are established mediators of tissue damage in stroke, and the role of dendritic cells (DCs) in inducing the early events of T cell activation and differentiation in stroke is not well understood.
METHODS: In a murine model of experimental stroke, we defined the immune phenotype of infiltrating DC subsets based on flow cytometry of surface markers, the expression of ontogenetic markers, and cytokine levels. We used conditional DC depletion, bone marrow chimeric mice, and IL-23 (interleukin-23) receptor-deficient mice to further explore the functional role of DCs.
RESULTS: We show that the ischemic brain was rapidly infiltrated by IRF4+/CD172a+ conventional type 2 DCs and that conventional type 2 DCs were the most abundant subset in comparison with all other DC subsets. Twenty-four hours after ischemia onset, conventional type 2 DCs became the major source of IL-23, promoting neutrophil infiltration by induction of IL-17 (interleukin-17) in γδ T cells. Functionally, the depletion of CD11c+ cells or the genetic disruption of the IL-23 signaling abrogated both IL-17 production in γδ T cells and neutrophil infiltration. Interruption of the IL-23/IL-17 cascade decreased infarct size and improved neurological outcome after stroke.
CONCLUSIONS: Our results suggest a central role for interferon regulatory factor 4-positive IL-23-producing conventional DCs in the IL-17-dependent secondary tissue damage in stroke.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  dendritic cells; inflammation; interleukin-17; interleukin-23; stroke

Mesh:

Substances:

Year:  2017        PMID: 29212740     DOI: 10.1161/STROKEAHA.117.019101

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

1.  Intravenous Immunoglobulin (IVIg) Induce a Protective Phenotype in Microglia Preventing Neuronal Cell Death in Ischaemic Stroke.

Authors:  Vivien Häußler; Tristan Daehn; Björn Rissiek; Vanessa Roth; Christian Gerloff; Thiruma V Arumugam; Tim Magnus; Mathias Gelderblom
Journal:  Neuromolecular Med       Date:  2019-09-26       Impact factor: 3.843

2.  Stem cell transplantation impairs dendritic cell trafficking and herpesvirus immunity.

Authors:  Carol A Wilke; Mathew M Chadwick; Paul R Chan; Bethany B Moore; Xiaofeng Zhou
Journal:  JCI Insight       Date:  2019-09-19

Review 3.  Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage.

Authors:  Lei Ye; Lu Gao; Hongwei Cheng
Journal:  Cell Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.046

4.  Anti-IL-23 exerted protective effects on cerebral ischemia-reperfusion injury through JAK2/STAT3 signaling pathway.

Authors:  Lichao Fan; Lichun Zhou
Journal:  Mol Biol Rep       Date:  2021-04-26       Impact factor: 2.316

5.  Distinct peripheral blood monocyte and neutrophil transcriptional programs following intracerebral hemorrhage and different etiologies of ischemic stroke.

Authors:  Paulina Carmona-Mora; Bradley P Ander; Glen C Jickling; Cheryl Dykstra-Aiello; Xinhua Zhan; Eva Ferino; Farah Hamade; Hajar Amini; Heather Hull; Frank R Sharp; Boryana Stamova
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-22       Impact factor: 6.200

Review 6.  Immune responses to stroke: mechanisms, modulation, and therapeutic potential.

Authors:  Costantino Iadecola; Marion S Buckwalter; Josef Anrather
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 7.  Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.

Authors:  Jun Tsuyama; Akari Nakamura; Hiroaki Ooboshi; Akihiko Yoshimura; Takashi Shichita
Journal:  Semin Immunopathol       Date:  2018-09-11       Impact factor: 9.623

Review 8.  Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 9.  Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly.

Authors:  Narayanappa Amruta; Abir A Rahman; Emmanuel Pinteaux; Gregory Bix
Journal:  J Neuroimmunol       Date:  2020-07-09       Impact factor: 3.478

Review 10.  Interleukin-17 and ischaemic stroke.

Authors:  Qiaohui Zhang; Yan Liao; Zhenquan Liu; Yajie Dai; Yunxin Li; Yue Li; Yibo Tang
Journal:  Immunology       Date:  2020-10-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.